====== Upton Allen ======

{{ :upton_allen_20130301_dsc7056-180x180.jpeg?150|}}

**Upton Allen** is a professor at the [[University of Toronto]]. He is chief, Division of Infectious Diseases, Hospital for Sick Children ([[SickKids]]). Dr. Allen is a senior associate scientist in the Research Institute, Hospital for Sick Children. His primary appointment is with the Division of Infectious Diseases, Department of Paediatrics. He is cross-appointed as a professor in the Institute of Health Policy, Management and Evaluation, University of Toronto.

Dr. Allen is a past director of the [[Infectious Diseases Society of America]] and a Fellow of the Society. He is a Fellow of the [[American Academy of Pediatrics]], the [[Royal College of Physicians and Surgeons of Canada]] and the [[Royal College of Physicians]] (UK). In 2018, he was awarded the [[Order of Ontario]], which is the highest honoured awarded by the province of Ontario, Canada.

Allen sits on the Behavioural Science Working Group of the [[Ontario COVID-19 Science Advisory Table]]. He completed two disclosure forms, neither of which report his funding from various pharmaceutical companies.((Allen, U. (2021, February 12). //Declaration of Interest.// Ontario COVID-19 Science Advisory Table. https://covid19-sciencetable.ca/wp-content/uploads/2021/02/Declaration-of-Interest_Behavioural-Science-Working-Group_Upton-Allen.pdf)) ((Allen, U. (2020, July 21). //Declaration of Interest.// Ontario COVID-19 Science Advisory Table. https://covid19-sciencetable.ca/wp-content/uploads/2020/07/Declaration-of-Interest_Science-Table_Upton-Allen.pdf)) 

On August 3, 2022, Allen replaced [[Adalsteinn Brown]] as co-chair of the OST.((//Ontario COVID-19 Science Advisory Table Leadership Update August 2022.// (2022, August 3). Public Health Ontario. https://archive.ph/24EaY))

===== Affiliations =====

==== American Academy of Pediatrics ====

Allen is a Fellow of the [[American Academy of Pediatrics]].

==== American Society of Transplantation ====

Allen is a member of the [[American Society of Transplantation]] Infectious Diseases Community of Practice, with which he’s published a paper titled “Influenza Vaccination in the Organ Transplant Recipient: Review and Summary Recommendations”. In his disclosures in the paper, Allen states he had received various forms of funding from Hoffman la [[Roche]], [[pharmaceutical_companies:pfizer|Pfizer]], and [[ADMA Biologics]].((Kumar, D., Blumberg, E. A., Danziger-Isakov, L., Kotton, C. N., Halasa, N. B., Ison, M. G., Avery, R. K., Green, M., Allen, U. D., Edwards, K. M., Miller, G., & Michaels, M. G. (2011). //Influenza Vaccination in the Organ Transplant Recipient: Review and Summary Recommendations.// American Journal of Transplantation, 11(10), 2020–2030. https://doi.org/10.1111/j.1600-6143.2011.03753.x)) This was not reported on his OST disclosure forms or biography.

==== Black Scientists' Task Force on Vaccine Equity ====

Allen is a member of the [[Black Scientists' Task Force on Vaccine Equity]].((Media Relations. (2021, February 3). //Black Scientists’ Task Force on Vaccine Equity.// City of Toronto. https://www.toronto.ca/news/black-scientists-task-force-on-vaccine-equity/))

==== Infectious Diseases Society of America ====

Allen is a former Director of the [[Infectious Diseases Society of America]], and is a fellow in the society. The society is funded through their foundation by [[AbbVie]], [[ALK]], [[Allergan]], the [[Alzheimer's Association]], [[American Academy of Insurance Medicine]], [[Bristol-Myers Squibb]], [[Capital for Good]] (an NGO with ties to the [[Clinton Foundation]], [[Vanguard]], [[UNESCO]], the [[United Nations]] (UN), the [[World Bank]] and the [[Peace Corps]]), [[Gilead]], [[Janssen]], [[The Medicines Company]] (since acquired by [[Novartis]]), [[Melinta Therapeutics]], [[Merck]], [[Morgan Stanley]], [[Open Society Foundations]] ([[George Soros]]), [[pharmaceutical_companies:pfizer|Pfizer]], [[Regeneron]], [[Seres Therapeutics]], [[Shionogi]], [[Takeda]] (member of [[BIOTECanada]] and [[Innovative Medicines Canada]]), [[Theravance Biopharma]], [[pharmaceutical_companies:Vertex]], and [[ViiV Healthcare]] (a merger of the HIV wings of Pfizer and [[GlaxoSmithKline]])((//2019-2020 Annual Report.// Infectious Diseases Society of America Foundation. Retrieved December 19, 2021, from https://secureservercdn.net/198.71.233.167/vj0.950.myftpupload.com/wp-content/uploads/2021/09/2021-09326-Foundation-Annual-Report-Interactive.pdf)) ((//Corporate Support.// Infectious Diseases Society of America Foundation. Retrieved December 19, 2021, from https://idsafoundation.org/giving/corporate-support/)) ((//2018 Annual Report.// Infectious Diseases Society of America Foundation. Retrieved December 19, 2021, from https://secureservercdn.net/198.71.233.167/vj0.950.myftpupload.com/wp-content/uploads/2021/09/Annual-Report-v7.pdf)) ((//2017 Annual Report.// Infectious Diseases Society of America Foundation. Retrieved December 20, 2021, from https://secureservercdn.net/198.71.233.167/vj0.950.myftpupload.com/wp-content/uploads/2021/09/IDSA-Foundation-Annual-Report-FINAL.pdf)) ((//2016 Annual Report.// Infectious Diseases Society of America Foundation. Retrieved December 20, 2021, from https://secureservercdn.net/198.71.233.167/vj0.950.myftpupload.com/wp-content/uploads/2021/09/Annual-Report-2016.pdf)) ((//2015 Annual Report.// Infectious Diseases Society of America Foundation. Retrieved December 20, 2021, from https://secureservercdn.net/198.71.233.167/vj0.950.myftpupload.com/wp-content/uploads/2021/09/IDSA-Foundation-Annual-Report-2015-Final.pdf)) ((//2014 Annual Report.// Infectious Diseases Society of America Foundation. Retrieved December 20, 2021, from https://secureservercdn.net/198.71.233.167/vj0.950.myftpupload.com/wp-content/uploads/2021/09/IDSAF_AnnualReport_Final_51115.pdf)) ((//2012 Annual Report.// Infectious Diseases Society of America Foundation. Retrieved December 20, 2021, from https://secureservercdn.net/198.71.233.167/vj0.950.myftpupload.com/wp-content/uploads/2021/09/Annual-Report-2012.pdf))

These ties to pharmaceutical companies were not reported in his OST disclosure forms and biography. Allen has contributed to publications funded by the society including “Charting the Path Forward: Development, Goals and Initiatives of the 2019 Infectious Diseases Society of America Strategic Plan”.((Sears, C. L., File, T. M., Alexander, B. D., McQuillen, D. P., MacIntyre, A. T., Allen, U. D., Colasanti, J. A., Siddiqui, J., Reveles, K. R., & Busky, C. (2019). //Charting the Path Forward: Development, Goals and Initiatives of the 2019 Infectious Diseases Society of America Strategic Plan.// Clinical Infectious Diseases, 69(12), e1–e7. https://doi.org/10.1093/cid/ciz1040))

==== Ontario COVID-19 Science Advisory Table ====

Allen sits on the Behavioural Science Working Group of the [[Ontario COVID-19 Science Advisory Table.]] He completed two disclosure forms, neither of which report his funding from various pharmaceutical companies.((Allen, U. (2021, February 12). //Declaration of Interest.// Ontario COVID-19 Science Advisory Table. https://covid19-sciencetable.ca/wp-content/uploads/2021/02/Declaration-of-Interest_Behavioural-Science-Working-Group_Upton-Allen.pdf)) ((Allen, U. (2020, July 21). //Declaration of Interest.// Ontario COVID-19 Science Advisory Table. https://covid19-sciencetable.ca/wp-content/uploads/2020/07/Declaration-of-Interest_Science-Table_Upton-Allen.pdf)) 

==== Province of Ontario ====

In 2018, Allen was awarded the Order of Ontario.((//Dr. Upton Allen appointed to Order of Ontario.// (2018, February 1). SickKids. https://www.sickkids.ca/en/news/archive/2018/dr.-upton-allen-appointed-to-order-of-ontario-/))

==== Royal College of Physicians (UK) ====

Allen is a Fellow of the [[Royal College of Physicians]] in the United Kingdom.

==== Royal College of Physicians and Surgeons of Canada ====

Allen is a Fellow of the [[Royal College of Physicians and Surgeons of Canada]].

==== SickKids ====

Allen is chief of the Division of Infectious Diseases and a Senior Associate Scientist in the Research Institute at the Hospital for Sick Children ([[SickKids]]).((//Upton Allen.// SickKids. Retrieved December 20, 2021, from https://www.sickkids.ca/en/staff/a/upton-allen/)) His profile lists funding from the [[Canadian Institutes of Health Research]] (CIHR), [[Alberta Innovates Health Solutions]], [[Enduring Heart Foundation]], [[AbbVie]], the [[University of Toronto]] and the [[SickKids Foundation]]. His relationship with AbbVie was not reported on his OST disclosure forms or biography. “Using the research infrastructure that he has created, he has been able to rapidly build a team to address host genetic susceptibility to COVID-19. In addition, he is leading studies addressing the immune response profiles due to COVID-19 in different age groups.”

Relevant articles include:

  * "Dr. Upton Allen from SickKids leads team assessing COVID-19 prevalence, risk factors among Black Canadian communities" (funded by [[SickKids]] and the [[University of Toronto]])((Luck, J. (2020, September 15). //Dr. Upton Allen from SickKids leads team assessing COVID-19 prevalence, risk factors among Black Canadian communities.// SickKids. https://www.sickkids.ca/en/news/archive/2020/upton-allen-sickkids-leads-team-assessing-covid-19-prevalence-risk-factors-among-black-canadian-communities/))
  * "SickKids researchers studying plasma of COVID-19 survivors" (funded by the [[Stollery Children’s Hospital Foundation]] and SickKids Foundation)((//SickKids researchers studying plasma of COVID-19 survivors.// (2020, May 29). SickKids. https://www.sickkids.ca/en/news/archive/2020/sickkids-researchers-studying-plasma-of-covid-19-survivors/))

==== The Transplantation Society International CMV Consensus Group ====

As a member of the CMV Consensus Group, Upton co-authored a paper titled “The Third International Consensus Guidelines on the Management of Cytomegalovirus in Solid-organ Transplantation”. The paper and the conference in question was funded by Hoffman La [[Roche]], [[Merck]], [[Oxford Immunotec]], [[Qiagen]], [[Shire]], [[CSL Behring]], [[Lophius Biosciences]], [[Chimerix]], [[Roche Molecular Systems]], and [[Abbott Laboratories]].((Kotton, C. N., Kumar, D., Caliendo, A. M., Huprikar, S., Chou, S., Danziger-Isakov, L., & Humar, A. (2018). //The Third International Consensus Guidelines on the Management of Cytomegalovirus in Solid-organ Transplantation.// Transplantation, 102(6), 900–931. https://doi.org/10.1097/tp.0000000000002191)) A similar paper called “Updated International Consensus Guidelines on the Management of Cytomegalovirus in Solid-Organ Transplantation” was published in 2013, funded by [[Roche]].((Kotton, C. N., Kumar, D., Caliendo, A. M., Åsberg, A., Chou, S., Danziger-Isakov, L., & Humar, A. (2013). //Updated International Consensus Guidelines on the Management of Cytomegalovirus in Solid-Organ Transplantation.// Transplantation, 96(4), 333–360. https://doi.org/10.1097/tp.0b013e31829df29d)) These pharmaceutical ties were not reported on his OST disclosure forms or biography.

==== University of Toronto ====

Allen is a Professor of Paediatrics and in the Institute of Health Policy, Management and Evaluation, University of Toronto.((University of Toronto. //Allen Upton.// Institute of Health Policy, Management and Evaluation. Retrieved December 20, 2021, from https://ihpme.utoronto.ca/faculty/allen-upton/))